2] Reynolds P, Dmitriev I, Curiel DT. Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector [J]. Gene Ther, 1999, 6(7): 1336-1339.
[3] 鲁建国, 林 晨, 黄志强. 腺病毒介导的p16 和顺铂的联合应用对胆管癌细胞系QBC939 裸鼠皮下移植瘤模型的治疗实验[J].第四军医大学学报, 2000, 21(7): 838-840.
[4] Hallenbeck PL, Chang YN, Hay C, et al. A novel tumor-speci-fic replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma [J]. Hum Gene Ther，1999，10 (10): 1721-1733.
[5] Yu DC, Sakamoto GT, Henderson DR. Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy [J]. Cancer Res，1999，59 (7): 1498-1504.
[6] Rothmann T, Hengstermann A, Whitaker NJ, et al. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells [J]. J Virol，1998，72 (12): 9470-9478.
[7] Ikeguchi M, Liu J, Kaibara N. Expression of survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatment [J]. Apoptosis， 2002，7(1): 23-29.
[8] Zhang B, Pan JS, Liu JY，et al. Effects of chemotherapy and/or radiotherapy on survivin expressionin ovarian cancer [J]. Methods Find Exp Clin Pharmacol，2006,28 (9): 619-625.
[9] Zhang B, Liu JY，Han SP, et al. Combined treatment of ionizing radiation with genistein on cervical cancer HeLa cells [J]. J Pharmacol Sci, 2006, 102 (1): 129-135.
[10] Kruyt FA, Curiel DT. Toward a new generation of conditionally replicating adenoviruses: pairing tumor selectivity with maximal oncolysis [J]. Hum Gene Ther, 2002,13 (4): 485-495.
[11] Yu DC, Chen Y, Dilley J, et al. Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel [J]. Cancer Res, 2001, 61 (2): 517-525.
[12] Li F, Altieri
上一页 [1] [2] [3] [4] [5] 下一页
您现在的位置： 绿色健康网 >> 医学论文 >> 妇产科论文 >> 正文